Loading…
Jaysynth Orgochem (BSE 524592)₹15.19+3.33%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Jaysynth Orgochem reported sales of ₹58.07 Cr, down 1.5% from Jun 2025, and net profit of ₹5.51 Cr, up 218.5% year on year. For the year to Mar 2026, sales were ₹260 Cr and net profit ₹15.01 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.42 | 50.66 | 55.76 | 50.30 | 57.40 | 60.29 | 59.73 | 58.98 | 65.77 | 65.28 | 69.44 | 58.07 |
| Expenses | 50.65 | 45.93 | 51.25 | 46.48 | 51.31 | 53.70 | 54.58 | 55.50 | 59.55 | 61.65 | 61.63 | 50.59 |
| Operating Profit | 6.04 | 4.87 | 4.66 | 4.05 | 6.32 | 6.76 | 5.36 | 3.70 | 6.36 | 3.90 | 7.98 | 7.64 |
| OPM % | 10.6% | 9.6% | 8.3% | 8.0% | 11.0% | 11.2% | 8.9% | 6.3% | 9.7% | 6.0% | 11.5% | 13.1% |
| Other Income | 0.41 | 0.58 | 1.19 | 0.91 | 0.54 | 1.50 | 0.46 | −0.07 | 1.56 | 0.52 | 1.00 | 0.77 |
| Interest | 0.08 | 0.09 | 0.28 | 0.52 | 0.32 | 0.55 | 0.46 | 0.40 | 0.42 | 0.42 | 0.38 | 0.37 |
| Depreciation | 0.61 | 0.64 | 0.71 | 0.57 | 0.77 | 0.68 | 0.72 | 0.68 | 0.69 | 0.69 | 0.59 | 0.64 |
| Profit before tax | 5.77 | 4.71 | 4.87 | 3.88 | 5.76 | 7.07 | 4.66 | 2.52 | 6.81 | 3.30 | 8.04 | 7.42 |
| Tax % | 16.2% | 28.0% | 30.4% | 26.4% | 26.4% | 22.7% | 34.3% | 32.0% | 27.6% | 29.6% | 29.6% | 25.8% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 4.83 | 3.40 | 3.38 | 2.87 | 4.25 | 5.47 | 3.07 | 1.73 | 4.96 | 2.34 | 5.67 | 5.51 |
| EPS (Rs) | 3.63 | 2.55 | 2.53 | 0.20 | 0.30 | 0.39 | 0.22 | 0.12 | 0.36 | 0.16 | 0.41 | 0.40 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales | 192 | 212 | 227 | 260 | 259 |
| Expenses | 189 | 195 | 204 | 239 | 233 |
| Operating Profit | 3.99 | 17.95 | 22.92 | 21.92 | 25.88 |
| OPM % | 2.1% | 8.0% | 9.9% | 8.0% | 10.0% |
| Other Income | 2.99 | 2.99 | 2.99 | 2.99 | 3.85 |
| Interest | 0.00 | 0.99 | 1.99 | 1.99 | 1.59 |
| Depreciation | 2.99 | 2.99 | 3.01 | 2.99 | 2.61 |
| Profit before tax | 3.01 | 17.01 | 20.99 | 21.01 | 25.57 |
| Tax % | 77.0% | 29.0% | 27.0% | 29.0% | — |
| Exceptional items | 0.35 | 0.56 | 0.93 | 0.00 | 0.00 |
| Net Profit | 1.01 | 12.01 | 16.02 | 15.01 | 18.48 |
| EPS (Rs) | 0.57 | 9.27 | 1.15 | 1.08 | 1.33 |
| Dividend payout % | 0.0% | 5.0% | 0.0% | 5.0% | — |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 13.00 | 13.01 | 13.02 | 13.00 |
| Reserves | 80.95 | 96.99 | 109 | 120 |
| Borrowings | 49.88 | 48.88 | 45.92 | 41.91 |
| Other Liabilities | 45.78 | 36.82 | 36.83 | 43.79 |
| Total Liabilities | 190 | 196 | 206 | 220 |
| Fixed Assets | 20.99 | 22.99 | 21.98 | 21.97 |
| CWIP | 0.00 | 0.00 | 0.99 | 4.98 |
| Investments | 20.92 | 25.89 | 25.88 | 10.95 |
| Other Assets | 148 | 148 | 157 | 181 |
| Inventories | 59.01 | 60.02 | 75.06 | 90.97 |
| Trade receivables | 45.97 | 47.99 | 46.93 | 64.98 |
| Cash & equivalents | 18.97 | 19.95 | 17.98 | 13.97 |
| Total Assets | 190 | 196 | 206 | 220 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 17.96 | 6.98 | 6.98 | −6.98 |
| Cash from investing activity | −10.01 | −6.01 | 1.01 | 12.02 |
| Cash from financing activity | −2.99 | 0.00 | −8.99 | −8.99 |
| Net cash flow | 6.01 | 0.00 | −2.01 | −4.01 |
| Capex | 4.14 | 2.95 | 2.97 | 6.68 |
| Free cash flow | 14.05 | 4.01 | 5.02 | −14.05 |
| CFO / OP % | 559.0% | 40.0% | 29.0% | −33.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 86 | 82 | 74 | 91 |
| Inventory days | 154 | 147 | 180 | 187 |
| Days payable | 96 | 73 | 64 | 64 |
| Cash conversion cycle | 146 | 158 | 193 | 215 |
| Working capital days | 135 | 146 | 149 | 184 |
| ROCE % | — | 11.0% | 13.1% | 13.1% |
For the Jun 2026 quarter, Jaysynth Orgochem reported sales of ₹58.07 Cr, down 1.5% year on year and net profit of ₹5.51 Cr, up 218.5% year on year. The operating margin was 13.1%.
Jaysynth Orgochem's sales for the year to Mar 2026 were ₹260 Cr; over the last twelve months they were ₹259 Cr.
Net profit for the year to Mar 2026 was ₹15.01 Cr, and ₹18.48 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.33.
Jaysynth Orgochem reported borrowings of ₹41.91 Cr at Mar 2026, against cash and equivalents of ₹13.97 Cr.
Cash from operations was −₹6.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹14.05 Cr.